|
News
Archive
Comments to the
NICHD
regarding
The FMR1 Premutation and POF.
Medical Education Affordability Act
endorsement
Comments
to the SACGHS
addressing oversight of genetic
testing.
Stakeholder
comments
to the CDC
Proficiency Testing Work Group.
Response to FDA
ASR and
IVDMIA draft guidances.
Response to CLIAC regarding
Genetics Specialty.
Response to
RFI regarding electronic
health records and personalized medicine.
AMP again provides
support for the Genetics Information Nondiscrimination Act (GINA) by
forwarding letters to the
House and
Senate through the
Genetic Alliance.
Read
the
February issue of the AMP Newsletter.
Summarizes
the
2006 Annual Meeting
(including great pictures from the photo contest). Subdivision and
Committee reports; special updates and announcements.
AMP
notes with deep sadness the untimely loss of Karen Snow-Bailey, a bright
light in molecular diagnostics.
Read remembrances of Karen submitted by her colleagues
and AMP Members.
Read
the
October issue of the
AMP Newsletter.
Announces election results, Final program for the 2006 Annual Meeting
and Corporate workshops; Subdivision and Committee reports; special updates
and announcements.
AMP
comments to the SACGHS regarding
Gene Patents
and the proposed
Large Population Study.
AMP
continues to support the preservation of the core functions of the Armed
Forces Institute of Pathology as a member of the AFIP Coalition, which is
organized by the CAP.
AMP
sends comments to CMS regarding
Medically Unbelievable Edits and
Equivalent QC
AMP
sends comments to FDA regarding
CFTR Gene Mutation Systems Guidance Document.
The Final SACGHS
Report on Coverage and Reimbursement of Genetic Tests and Services is now
available at
http://www4.od.nih.gov/oba/sacghs/reports/CR_report.pdf.
Read
the
June issue of the AMP
Newsletter. Announces the recipient of the AMP Leadership Award;
preliminary program for the 2006 Annual Meeting; Subdivison and Committee
reports; special updates and announcements.
AMP again provides
support for the Genetics Information Nondiscrimination Act (GINA) by
forwarding letters to the
House and
Senate through the
Genetic Alliance.
Read
the
February issue of the AMP Newsletter.
Summarizes
the
2006 Annual Meeting
(including great pictures from the photo contest). Subdivision and
Committee reports; special updates and announcements.
AMP
notes with deep sadness the untimely loss of Karen Snow-Bailey, a bright
light in molecular diagnostics.
Read remembrances of Karen submitted by her colleagues
and AMP Members.
Read
the
October issue of the
AMP Newsletter.
Announces election results, Final program for the 2006 Annual Meeting
and Corporate workshops; Subdivision and Committee reports; special updates
and announcements.
AMP
comments to the SACGHS regarding
Gene Patents
and the proposed
Large Population Study.
AMP
continues to support the preservation of the core functions of the Armed
Forces Institute of Pathology as a member of the AFIP Coalition, which is
organized by the CAP.
AMP
sends comments to CMS regarding
Medically Unbelievable Edits and
Equivalent QC
AMP
sends comments to FDA regarding
CFTR Gene Mutation Systems Guidance Document.
The Final SACGHS
Report on Coverage and Reimbursement of Genetic Tests and Services is now
available at
http://www4.od.nih.gov/oba/
sacghs/reports/CR_report.pdf.
Read
the
June issue of the AMP
Newsletter. Announces the recipient of the AMP Leadership Award;
preliminary program for the 2006 Annual Meeting; Subdivison and Committee
reports; special updates and announcements.
The
new AMP Jobs Board located at
www.PathologyJobsToday.org offers both job seekers and
employers/recruiters an interactive venue for finding and posting job
opportunities. Job seekers can post their resume anonymously, view the
latest jobs in pathology, and create a free personal Job Seeker Account.
Employers and recruiters can view the Resumes and CVs, create an Employer
Account, and post their jobs online quickly and easily.
AMP
Executive Officer Mark E. Sobel, MD, PhD, comments on the Labcorp v.
Metabolite case in the March 2006 issue of the AAMC
Reporter (print version only).
“If the court rules for Metabolite in this case, we feel that it could put
in jeopardy all forms of laboratory testing,” said Dr. Sobel. Read the
amici curae brief filed on
behalf of Labcorp as well as AMP’s position on patent
and licensing practices in the
Professional
Relations
section of our website.
The Final
SACGHS Report on Coverage and Reimbursement of Genetic Tests and Services is
now available at
http://www4.od.nih.gov/oba/
sacghs/reports/CR_report.pdf.
Read
the
February issue of the AMP Newsletter
Includes
information about the JMD CME Program; an overview of the 2005 Annual
Meeting; Subdivision and Committee reports; and special updates and
announcements.
AMP
joined the American Medical Association (AMA) and several other medical
organizations on Dec 23, 2005 in filing a brief as
amici curiae "friends of the
court" in the LabCorp v. Metabolite
case now before the U.S. Supreme Court.
Read the brief.
The November 9,
2005 meeting of the Cystic Fibrosis Reporting Group is reported as the
January 2006 CAP Today cover story,
“Straight talk on molecular reports”
by William Check, PhD
and highlights AMP members.
AMP
Executive Officer Mark Sobel, MD, PhD is interviewed by ADVANCE for Medical
Laboratory Professionals regarding the use of microarrays in the clinical
laboratory.
Read the story.
JMD
CME Program in Molecular Diagnostics
2005 Committee Summary Reports
are available.
AMP
provides comments to FDA recommending the inclusion of pharmacogenetic information in proposed drug
safety communication tools.
Read the
October issue of the AMP Newsletter.
Includes election results; Annual Meeting
Preliminary Program; Subdivision and Committee reports; and special
updates and announcements.
AMP provides comments to the National Heritage
Insurance Company
on the Local Coverage Determination for the Oncotype
DX Test for breast cancer prognosis.
Read
the letter
AMP co-signs letter
urging Trailblazer to
expand the number of disease entities for which cytogenetics tests and
FISH technology should be reimbursed.
Read the letter
Jeffrey A. Kant, MD, PhD chosen as the first recipient of the AMP
Leadership Award.
This new
award is bestowed each year to an AMP member who has demonstrated
exceptional leadership in the accomplishment of the mission and goals of
AMP. Supported by a grant from Abbott
Molecular Diagnostics.
Read
the June 2005 issue of the AMP Newsletter.
Includes the 2005 Annual Meeting Preliminary Program, Subdivision and
Committee reports, and more about the AMP Leadership Award
AMP provides comments on the SACGHS draft report, “Coverage and
Reimbursement of Genetic Tests and Services.”
AMP co-signs letter to Secretary Michael O. Leavitt, urging a
re-evaluation of Cytology Proficiency Testing.
Two recent
CAP Today cover stories by
William Check, PhD highlight AMP members:
On microchips, directing a cast of thousands,
April 2005
Lymphoma microarrays stir up debate, March 2005
AMP position is presented March 1, 2005 to the
SACGHS.
February 15, 2005. AMP sends a Letter
of Support for S.306, the Genetic Nondiscrimination Act.
January 18, 2005. AMP provides
comments regarding the NIH proposed “Best Practices for the Licensing of
Genomic Inventions.”
2004
Annual Meeting Presentations are available in the AMP
Web Library.
2004 Committee and
Subdivision Reports now available.
AMP celebrated its 10th Anniversary at
the Annual Meeting November 11-13, 2004 with a record number of attendees
and exhibitors.
Read the special Anniversary
edition of the
AMP Newsletter.

Pictured (L to R) at the Anniversary Cake are some of the AMP Past
Presidents as well as the current President, President-elects, and Chair
of the AMP Action Committee (which formally established AMP): Peggy
Gulley (Pres. 1997), David Cooper (Chair, AMP Action
Committee), Debra Leonard (Pres. 2000), Dan Farkas (Pres.
2003), Angie Caliendo (Pres. 2004), Mark Sobel (Pres. 1999),
Barbara Zehnbauer (Pres. 2006), Mark Lovell (Pres. 2005),
Karen Kaul (Pres. 2002), and Jeffrey Kant (Pres. 1996).
AMP responds to a controversial new policy, proposed
by the National Institutes of Health (NIH) concerning the publication of
research supported by NIH funding.
Read the NIH Proposed Policy
Read the AMP Response
Free Access To Science: A Model For The Dissemination Of Scientific
Literature
Association for
Molecular Pathology commits to providing free access to medical and
scientific research
Roche Sponsors AMP Award for
Excellence in Molecular Diagnostics.
AMP is pleased to announce that Roche Diagnostics
Corporation will sponsor the
AMP Award for Excellence in Molecular Diagnostics through a
generous partnership from 2004-2008.
(View Press Release)
04/30/2008 |